Entasis Therapeutics Holdings Inc
NASDAQ:ETTX

Watchlist Manager
Entasis Therapeutics Holdings Inc Logo
Entasis Therapeutics Holdings Inc
NASDAQ:ETTX
Watchlist
Price: 2.19 USD Market Closed
Updated: May 30, 2024

Entasis Therapeutics Holdings Inc
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Entasis Therapeutics Holdings Inc
Total Other Income Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Entasis Therapeutics Holdings Inc
NASDAQ:ETTX
Total Other Income
$5.2m
CAGR 3-Years
-1%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Total Other Income
-$3.5B
CAGR 3-Years
12%
CAGR 5-Years
-62%
CAGR 10-Years
-78%
Gilead Sciences Inc
NASDAQ:GILD
Total Other Income
$158m
CAGR 3-Years
4%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Total Other Income
$151m
CAGR 3-Years
126%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Other Income
-$55.2m
CAGR 3-Years
N/A
CAGR 5-Years
1%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Other Income
-$31.6m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Entasis Therapeutics Holdings Inc's Total Other Income?
Total Other Income
5.2m USD

Based on the financial report for Dec 31, 2021, Entasis Therapeutics Holdings Inc's Total Other Income amounts to 5.2m USD.

What is Entasis Therapeutics Holdings Inc's Total Other Income growth rate?
Total Other Income CAGR 3Y
-1%

Over the last year, the Total Other Income growth was 45%. The average annual Total Other Income growth rates for Entasis Therapeutics Holdings Inc have been -1% over the past three years .